Elevance Health (ELV): insider & executive buying
Elevance Health · Health Care · ref. ETF XLV · price $399.11
In short — 3 insiders bought Elevance Health over ~6 months (3 buys, total $2.2M, latest Jul 17, 26) — cluster buy. Public Form 4 data, informative (not a performance signal).
Are Elevance Health's executives buying their own shares? Here are the disclosed insider buys over the last 6 months — a transparency data point, not an outperformance signal.
📈 1-year price
$399.11+28.6% over range
Aug 28, 25low $280.74 · high $426.79Aug 27, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
72% recommend buying · 18 analysts
Latest insider buys on Elevance Health
| Date | Insider | Role | Shares | Amount |
|---|---|---|---|---|
| Jul 17, 26 | Peru Ramiro G | Dir | 1,000 | $366k |
| Jul 17, 26 | Boudreaux Gail | Pres, CEO | 2,725 | $1.0M |
| Mar 5, 26 | Collis Steven H | Dir | 3,000 | $870k |
⚠️ Open-market buys reported to the SEC (Form 4). Transparency data, not advice nor an outperformance signal (our backtests show no reliable edge).
Frequently asked questions
Have Elevance Health's executives bought shares recently?
3 Elevance Health insider(s) bought $2.2M over ~6 months (latest Jul 17, 26). A buy shows confidence, but our backtests show no performance edge.
Is insider buying a good signal for ELV?
It's useful transparency data, but NOT a performance guarantee: our historical tests show no reliable edge from following insider buys. Cross-check with fundamentals and analyst views.
Where does this data come from?
From Form 4 filings with the SEC (mandatory for officers and 10%+ holders), aggregated and refreshed regularly.
💬 A question about Elevance Health? The JPI assistant answers using our backtest data.